Platelet [cell]
Response [orga]
Aspirin [orch, phsu]
mg% [qnco]
Patients [podg]
coronary [bpoc]
Heart disease [dsyn]
Five [qnco]
Aspirin [orch, phsu]
Decrease [qlco]
cardiovascular events [fndg]
Aspirin [orch, phsu]
therapy [ftcn]
Patients [podg]
arterial vascular disease [dsyn]
Events [evnt]
Meta-Analysis [inpr]
antiplatelet therapy [topp]
Progressive [ftcn]
Decrease [qlco]
Efficacy [qlco]
Aspirin [orch, phsu]
Decreased Sensitivity [fndg]
Aspirin [orch, phsu]
therapy [ftcn]
prospective [resa]
Randomized Clinical Trial [inpr, resa]
serial [inpr, mnob]
Monitoring [hlca]
Conduct [inbe]
Patients [podg]
Documented [hlca]
coronary heart disease [dsyn]
investigated [ftcn]
long-term treatment [hlca]
Aspirin [orch, phsu]
mg% [qnco]
Affect [menp]
Platelet [cell]
Response [orga]
occurrence [ftcn]
cardiovascular events [fndg]
Documented [hlca]
Platelet [cell]
Sensitivity [qnco]
Aspirin [orch, phsu]
Prostacyclin [bacs, eico, phsu]
Adenosine Diphosphate [bacs, nnon]
Collagen [aapp, bacs, bodm]
Epinephrine induced platelet aggregation [clna]
Evaluated [ftcn]
Addition [ftcn]
beta-Thromboglobulin [aapp, bacs]
Inflammatory [ftcn]
Marker [clna]
Measured [qlco]
Patients [podg]
Lost [ftcn]
Patients [podg]
Died [orgf]
Eleven [qnco]
Patients [podg]
cardiovascular events [fndg]
Group [idcn]
Platelet [cell]
Response [orga]
Aspirin [orch, phsu]
Referenced [cnce]
variables [qlco]
Unchanged [fndg]
Patients [podg]
cardiovascular events [fndg]
Last [qlco]
Monitoring [hlca]
Interval [tmco]
Revealed [qlco]
Platelet [cell]
Response [orga]
Aspirin [orch, phsu]
Patients [podg]
Fatal [qlco]
cardiovascular events [fndg]
Increased [qnco]
Inflammatory [ftcn]
Marker [clna]
Patients [podg]
cardiovascular events [fndg]
Aspirin [orch, phsu]
mg% [qnco]
Intake [ftcn]
Study [mnob]
Revealed [qlco]
Response [orga]
Aspirin [orch, phsu]
mg% [qnco]
cardiovascular events [fndg]
Patients [podg]
coronary heart disease [dsyn]
Reserve [acty]
